Market News

GSK to exit Nigeria after 51 years of operations

GlaxoSmithKline (GSK), a British multinational pharmaceutical and biotechnology company has announced plans to exit Nigeria, after 51 years of operation in Nigeria. “In our published Q2 results we disclosed that the GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialization of its prescription medicines and vaccines in Nigeria
read more GSK to exit Nigeria after 51 years of operationsBusinessday NGRead More

At Reward Investments and Services Limited, our priority is to provide customers with premium capital market services, rewarding investments and desired results.

Contact Us

Powered by  MTL


© 2020-Reward Investments & Services Ltd. All rights reserved.

Scroll to Top